The fine specificity, but not the invasion inhibitory activity, of 19-kilodalton merozoite surface protein 1-specific antibodies is associated with resistance to malarial parasitemia in a cross-sectional survey in the Gambia

被引:51
作者
Corran, PH
O'Donnell, RA
Todd, J
Uthaipibull, C
Holder, AA
Crabb, BS
Riley, EM
机构
[1] Univ London London Sch Hyg & Trop Med, Dept Infect & Trop Dis, London WC1E 7HT, England
[2] Natl Inst Med Res, Div Parasitol, London NW7 1AA, England
[3] Natl Inst Biol Stand & Controls, Immunobiol Div, S Mimms, Herts, England
[4] Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3050, Australia
基金
英国医学研究理事会;
关键词
D O I
10.1128/IAI.72.10.6185-6189.2004
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
In a cross-sectional survey of 187 Gambian children and adults, we have analyzed prevalence, fine specificity, and 19-kilodalton merozoite surface protein 1 (MSP-1(19))-specific erythrocyte invasion inhibitory activity of antibodies to MSP-1(19) but find no significant association between any of these parameters and prevalence or density of malarial parasitemia, except that, after correcting for total anti-MSP-1(19) antibody levels, individuals with anti-MSP-1(19) antibodies that compete with an invasion inhibitory monoclonal antibody (12.10) were significantly less likely to have malaria infections with densities of greater than or equal to1,000 parasites/mul than were individuals without such antibodies. This association persisted after correction for age and ethnic origin.
引用
收藏
页码:6185 / 6189
页数:5
相关论文
共 26 条
[1]   Development and pre-clinical analysis of a Plasmodium falciparum Merozoite Surface Protein-142 malaria vaccine [J].
Angov, E ;
Aufiero, BM ;
Turgeon, AM ;
Van Handenhove, M ;
Ockenhouse, CF ;
Kester, KE ;
Walsh, DS ;
McBride, JS ;
Dubois, MC ;
Cohen, J ;
Haynes, JD ;
Eckels, KH ;
Heppner, DG ;
Ballou, WR ;
Diggs, CL ;
Lyon, JA .
MOLECULAR AND BIOCHEMICAL PARASITOLOGY, 2003, 128 (02) :195-204
[2]   ANTIBODIES INHIBIT THE PROTEASE-MEDIATED PROCESSING OF A MALARIA MEROZOITE SURFACE PROTEIN [J].
BLACKMAN, MJ ;
SCOTTFINNIGAN, TJ ;
SHAI, S ;
HOLDER, AA .
JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 180 (01) :389-393
[3]   Association of the IgG response to Plasmodium falciparum merozoite protein (C-terminal 19 kD) with clinical immunity to malaria in the Brazilian Amazon region [J].
Braga, TM ;
Barros, RM ;
Reis, TA ;
Fontes, CJF ;
Morais, CG ;
Martins, MS ;
Krettli, AU .
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2002, 66 (05) :461-466
[4]   A recombinant Baculovirus 42-kilodalton c-terminal fragment of Plasmodium falciparum merozoite surface protein 1 protects Aotus monkeys against malaria [J].
Chang, SP ;
Case, SE ;
Gosnell, WL ;
Kramer, KJ ;
Tam, LQ ;
Hashiro, CQ ;
Nikaido, CM ;
Gibson, HL ;
LeeNg, CT ;
Barr, PJ ;
Yokota, BT ;
Hui, GSN .
INFECTION AND IMMUNITY, 1996, 64 (01) :253-261
[5]   A RECOMBINANT 15-KILODALTON CARBOXYL-TERMINAL FRAGMENT OF PLASMODIUM-YOELII-YOELII 17XL MEROZOITE SURFACE PROTEIN-1 INDUCES A PROTECTIVE IMMUNE-RESPONSE IN MICE [J].
DALY, TM ;
LONG, CA .
INFECTION AND IMMUNITY, 1993, 61 (06) :2462-2467
[6]   A new rodent model to assess blood stage immunity to the Plasmodium falciparum antigen merozoite surface protein 119 reveals a protective role for invasion inhibitory antibodies [J].
de Koning-Ward, TF ;
O'Donnell, RA ;
Drew, DR ;
Thomson, R ;
Speed, TP ;
Crabb, BS .
JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 198 (06) :869-875
[7]   Levels of antibody to conserved parts of Plasmodium falciparum merozoite surface protein 1 in Ghanaian children are not associated with protection from clinical malaria [J].
Dodoo, D ;
Theander, TG ;
Kurtzhals, JAL ;
Koram, K ;
Riley, E ;
Akanmori, BD ;
Nkrumah, FK ;
Hviid, L .
INFECTION AND IMMUNITY, 1999, 67 (05) :2131-2137
[8]   SERUM ANTIBODIES FROM MALARIA-EXPOSED PEOPLE RECOGNIZE CONSERVED EPITOPES FORMED BY THE 2 EPIDERMAL GROWTH-FACTOR MOTIFS OF MSP1(19), THE CARBOXY-TERMINAL FRAGMENT OF THE MAJOR MEROZOITE SURFACE PROTEIN OF PLASMODIUM-FALCIPARUM [J].
EGAN, AF ;
CHAPPEL, JA ;
BURGHAUS, PA ;
MORRIS, JS ;
MCBRIDE, JS ;
HOLDER, AA ;
KASLOW, DC ;
RILEY, EM .
INFECTION AND IMMUNITY, 1995, 63 (02) :456-466
[9]   Clinical immunity to Plasmodium falciparum malaria is associated with serum antibodies to the 19-kDa C-terminal fragment of the merozoite surface antigen, PfMSP-1 [J].
Egan, AF ;
Morris, J ;
Barnish, G ;
Allen, S ;
Greenwood, BM ;
Kaslow, DC ;
Holder, AA ;
Riley, EM .
JOURNAL OF INFECTIOUS DISEASES, 1996, 173 (03) :765-769
[10]   Human antibodies to the 19 kDa C-terminal fragment of Plasmodium falciparum merozoite surface protein 1 inhibit parasite growth in vitro [J].
Egan, AF ;
Burghaus, P ;
Druilhe, P ;
Holder, AA ;
Riley, EM .
PARASITE IMMUNOLOGY, 1999, 21 (03) :133-139